Literature DB >> 30810062

Dynamic changes in histone deacetylases following kidney ischemia-reperfusion injury are critical for promoting proximal tubule proliferation.

Kelly A Hyndman1, Malgorzata Kasztan1, Luciano D Mendoza1, Sureena Monteiro-Pai1.   

Abstract

Deranged histone deacetylase (HDAC) activity causes uncontrolled proliferation, inflammation, fibrosis, and organ damage. It is unclear whether deranged HDAC activity results in acute kidney injury in the renal hypoperfusion model of bilateral ischemia-reperfusion injury (IRI) and whether in vivo inhibition is an appropriate therapeutic approach to limit injury. Male mice were implanted with intraperitoneal osmotic minipumps containing vehicle, the class I HDAC inhibitor, MS275, or the pan-HDAC inhibitor, trichostatin A (TSA), 3 days before sham/bilateral IRI surgery. Kidney cortical samples were analyzed using histological, immunohistochemical, and Western blotting techniques. HDAC-dependent proliferation rate was measured in immortalized rat epithelial cells and primary mouse or human proximal tubule (PT) cells. There were dynamic changes in cortical HDAC localization and abundance following IRI including a fourfold increase in HDAC4 in the PT. HDAC inhibition resulted in a significantly higher plasma creatinine, increased kidney damage, but reduced interstitial fibrosis compared with vehicle-treated IRI mice. HDAC-inhibited mice had reduced interstitial α-smooth muscle actin, fibronectin expression, and Sirius red-positive area, suggesting that IRI activates HDAC-mediated fibrotic pathways. In vivo proliferation of the kidney epithelium was significantly reduced in TSA-treated, but not MS275-treated, IRI mice, suggesting class II HDACs mediate proliferation. Furthermore, HDAC4 activation increased proliferation of human and mouse PTs. Kidney HDACs are activated during IRI with isoform-specific expression patterns. Our data point to mechanisms whereby IRI activates HDACs resulting in fibrotic pathways but also activation of PT proliferation and repair pathways. This study demonstrates the need to develop isoform-selective HDAC inhibitors for the treatment of renal hypoperfusion-induced injury.

Entities:  

Keywords:  fibrosis; histone deacetylase; ischemia-reperfusion injury; kidney cortex; proliferation; proximal tubule

Mesh:

Substances:

Year:  2019        PMID: 30810062      PMCID: PMC6580243          DOI: 10.1152/ajprenal.00499.2018

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  63 in total

Review 1.  Emerging approaches for histone deacetylase inhibitor drug discovery.

Authors:  Clemens Zwergel; Sergio Valente; Claus Jacob; Antonello Mai
Journal:  Expert Opin Drug Discov       Date:  2015-04-20       Impact factor: 6.098

2.  Improved renal ischemia tolerance in females influences kidney transplantation outcomes.

Authors:  David D Aufhauser; Zhonglin Wang; Douglas R Murken; Tricia R Bhatti; Yanfeng Wang; Guanghui Ge; Robert R Redfield; Peter L Abt; Liqing Wang; Nikolaos Svoronos; Arwin Thomasson; Peter P Reese; Wayne W Hancock; Matthew H Levine
Journal:  J Clin Invest       Date:  2016-04-18       Impact factor: 14.808

Review 3.  HDACs and HDAC Inhibitors in Cancer Development and Therapy.

Authors:  Yixuan Li; Edward Seto
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

4.  Blockade of histone deacetylase 6 protects against cisplatin-induced acute kidney injury.

Authors:  Jinhua Tang; Yingfeng Shi; Na Liu; Liuqing Xu; Xiujuan Zang; Peibin Li; Juanlian Zhang; Xiaoqing Zheng; Andong Qiu; Shougang Zhuang
Journal:  Clin Sci (Lond)       Date:  2018-02-02       Impact factor: 6.124

5.  Class I HDAC activity is required for renal protection and regeneration after acute kidney injury.

Authors:  Jinhua Tang; Yanli Yan; Ting C Zhao; Rujun Gong; George Bayliss; Haidong Yan; Shougang Zhuang
Journal:  Am J Physiol Renal Physiol       Date:  2014-05-07

6.  Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study.

Authors:  Andrea Lassnigg; Daniel Schmidlin; Mohamed Mouhieddine; Lucas M Bachmann; Wilfred Druml; Peter Bauer; Michael Hiesmayr
Journal:  J Am Soc Nephrol       Date:  2004-06       Impact factor: 10.121

7.  A PTBA small molecule enhances recovery and reduces postinjury fibrosis after aristolochic acid-induced kidney injury.

Authors:  Tatiana Novitskaya; Lee McDermott; Ke Xin Zhang; Takuto Chiba; Paisit Paueksakon; Neil A Hukriede; Mark P de Caestecker
Journal:  Am J Physiol Renal Physiol       Date:  2013-12-26

8.  HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 transcriptional activity.

Authors:  Niek G J Leus; Petra E van der Wouden; Thea van den Bosch; Wouter T R Hooghiemstra; Maria E Ourailidou; Loes E M Kistemaker; Rainer Bischoff; Reinoud Gosens; Hidde J Haisma; Frank J Dekker
Journal:  Biochem Pharmacol       Date:  2016-03-16       Impact factor: 5.858

9.  Inhibition of histone deacetylase 1 ameliorates renal tubulointerstitial fibrosis via modulation of inflammation and extracellular matrix gene transcription in mice.

Authors:  Tùng Nguyễn-Thanh; Dal Kim; Sik Lee; Won Kim; Sung Kwang Park; Kyung Pyo Kang
Journal:  Int J Mol Med       Date:  2017-10-27       Impact factor: 4.101

10.  Histone deacetylase inhibitors protect against cisplatin-induced acute kidney injury by activating autophagy in proximal tubular cells.

Authors:  Jing Liu; Man J Livingston; Guie Dong; Chengyuan Tang; Yunchao Su; Guangyu Wu; Xiao-Ming Yin; Zheng Dong
Journal:  Cell Death Dis       Date:  2018-02-23       Impact factor: 8.469

View more
  10 in total

1.  Validation of HDAC8 Inhibitors as Drug Discovery Starting Points to Treat Acute Kidney Injury.

Authors:  Keith Long; Zoe Vaughn; Michael David McDaniels; Sipak Joyasawal; Aneta Przepiorski; Emily Parasky; Veronika Sander; David Close; Paul A Johnston; Alan J Davidson; Mark de Caestecker; Neil A Hukriede; Donna M Huryn
Journal:  ACS Pharmacol Transl Sci       Date:  2022-03-16

2.  Kidney cell type-specific changes in the chromatin and transcriptome landscapes following epithelial Hdac1 and Hdac2 knockdown.

Authors:  Kelly A Hyndman; David K Crossman
Journal:  Physiol Genomics       Date:  2021-12-10       Impact factor: 3.107

Review 3.  Histone Deacetylases in Kidney Physiology and Acute Kidney Injury.

Authors:  Kelly A Hyndman
Journal:  Semin Nephrol       Date:  2020-03       Impact factor: 5.299

4.  Class IIa HDAC inhibitor TMP195 alleviates lipopolysaccharide-induced acute kidney injury.

Authors:  Wei Zhang; Yinjie Guan; George Bayliss; Shougang Zhuang
Journal:  Am J Physiol Renal Physiol       Date:  2020-10-05

Review 5.  UAB-UCSD O'Brien Center for Acute Kidney Injury Research.

Authors:  Lisa M Curtis; James George; Volker Vallon; Stephen Barnes; Victor Darley-Usmar; Sucheta Vaingankar; Gary R Cutter; Orlando M Gutierrez; Michael Seifert; Joachim H Ix; Ravindra L Mehta; Paul W Sanders; Anupam Agarwal
Journal:  Am J Physiol Renal Physiol       Date:  2021-03-29

6.  Correlation analysis between expression of histone deacetylase 6 and clinical parameters in IgA nephropathy patients.

Authors:  Yan Hu; Minghua Shang; Yingfeng Shi; Min Tao; Weijie Yuan; Lunxian Tang; Xiaoyan Ma; Binbin Cui; Hui Chen; Xun Zhou; Shougang Zhuang; Na Liu
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

7.  Depleted HDAC3 attenuates hyperuricemia-induced renal interstitial fibrosis via miR-19b-3p/SF3B3 axis.

Authors:  Langtao Hu; Kai Yang; Xing Mai; Jiali Wei; Chunyang Ma
Journal:  Cell Cycle       Date:  2022-01-13       Impact factor: 5.173

Review 8.  Molecular mechanisms of histone deacetylases and inhibitors in renal fibrosis progression.

Authors:  Jiayu Wang; Jiaxing Li; Xin Zhang; Min Zhang; Xiaopeng Hu; Hang Yin
Journal:  Front Mol Biosci       Date:  2022-09-06

Review 9.  The Role and Mechanism of Histone Deacetylases in Acute Kidney Injury.

Authors:  Xun Zhou; Hui Chen; Yingfeng Shi; Xiaoyan Ma; Shougang Zhuang; Na Liu
Journal:  Front Pharmacol       Date:  2021-06-16       Impact factor: 5.810

10.  Fluid-electrolyte homeostasis requires histone deacetylase function.

Authors:  Kelly A Hyndman; Joshua S Speed; Luciano D Mendoza; John M Allan; Jackson Colson; Randee Sedaka; Chunhua Jin; Hyun Jun Jung; Samir El-Dahr; David M Pollock; Jennifer S Pollock
Journal:  JCI Insight       Date:  2020-08-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.